WeChat

 

News

MORE
Prev
Next
2024-03-13

Prof. Ningshao Xia's team reveals mechanisms behind the impaired response of antigen-specific B cells to therapeutic vaccination in chronic hepatitis B virus infection

The HBsAg-specific BCR knock-in mouse was constructed to study the characteristics of B cells in chronic HBV infection. An atypical pre-plasma cell population was identified post therapeutic vaccination in chronic HBV carrier mice. Atypical pre-plasma cells display enhanced BCR signaling, ER stress and apoptosis-related gene expression. Combination therapy (antibody + vaccine) partially ...

2024-03-13

Prof. Ningshao Xia's team publishes ten-year efficacy monitoring results of the world's only Hepatitis E vaccine in The Lancet

Hepatitis E virus (HEV) is a frequently overlooked causative agent of acute hepatitis. Evaluating the long-term durability of hepatitis E vaccine efficacy holds crucial importance. This study was an extension to a randomised, double-blind, placebo-controlled, phase-3 clinical trial of the hepatitis E vaccine conducted in Dontai County, Jiangsu, China. Participants were re...

2023-09-13

Prof. Ningshao Xia's Team Discovers New Nasopharyngeal Cancer Screening and Early Diagnosis Markers

Nasopharyngeal cancer is closely related to EBV infection, and China is a high incidence area, accounting for about half of the world's new cases every year. Early symptoms of nasopharyngeal cancer are not typical enough, and about 80% of patients are already in the middle or late stage when they are diagnosed, with poor treatment effect, short survival time and low quality of life. Screening b...

Research

MORE

Lectures

MORE